ERBB2 and neoplasm: The authors combined the DOPE : PADRE : MPL liposome with P5 peptide derived from HER2/neu breast cancer epitopes, and found reduced tumour growth and increased survival time in mice vaccinated with the P5+DOPE : PADRE : MPL liposomes (102).